Summary During [1968][1969][1970][1971][1972][1973][1974][1975][1976][1977][1978][1979][1980], 1176 women aged 16-50 years with newly diagnosed breast cancer and a like number of matched controls were interviewed at 9 teaching hospitals in London and Oxford and asked about their use of oral contraceptives. The results were reassuring. A few statistically significant differences in oral contraceptive use were found between the breast cancer and control groups, but the data were subdivided in many ways so that some "significant" differences would have been expected through the play of chance alone. Certainly no patterns of risk emerged which would suggest that any of the associations were causal. It must be stressed, however, that the data are still sparse in some importanr subcategories-for example, only small numbers of both cases and controls had prolonged oral contraceptive use before their first term pregnancy. For this reason, it is important that information on the possible relationship between pill use and breast cancer should continue to be collected. Women who had never used oral contraceptives presented with appreciably more advanced tumours than those who had been using oral contraceptives during the year before detection of cancer, while past users were in an intermediate position. These differences in staging were reflected in the pattern of survival. Possible explanations for these observations include "surveillance bias" among oral contraceptive users leading to earlier diagnosis and a beneficial biological effect of oral contraceptives on tumour growth and spread. Women with breast cancer reported never having used any method of contraception and heavy cigarette smoking (> 15 per day) significantly less often than controls. We could find no obvious explanation for the former observation, but suspect that the latter reflects the unrepresentative smoking habits of our hospital controls rather than a protective effect of smoking against breast cancer.
In December 1968, we began a case-control study of the use of oral contraceptives by women admitted to hospital for primary treatment of cancer of the breast. Since then, 3 progress reports have been published concerning 90, 322, and 621 cases respectively while, in addition, a detailed analysis of oral contraceptive use before first term pregnancy by 1176 cases has been described (Vessey et al., 1972 (Vessey et al., , 1975 (Vessey et al., , 1979 . None of the results has provided much indication of any relationship, either positive or negative, between pill use and breast cancer risk. We now present a brief summary of our findings (other than those already given by Vessey et al., 1982) from the final total of 1176 patients with cancer of the breast admitted to hospital before the end of the study, on September 30th, 1980.
Subjects and methods
In brief, married women aged 16-50y, who were under treatment for newly diagnosed and histologically proven breast cancer at University College, the Royal Free, the Middlesex, Charing Cross, Guy's & Mount Vernon hospitals, London and the Radcliffe Infirmary, John Radcliffe and Churchill hospitals, Oxford, were interviewed by a trained medical social worker or nurse about their medical, social, obstetric, menstrual, and contraceptive histories. For each patient a married control was selected from women inpatients in the same hospital who had certain acute medical or surgical conditions or had been admitted for routine elective operations that were considered unlikely to be associated with the use or lack of use of any contraceptive. The control women matched the women with breast cancer within 5-year age groups (within 5 years of age prior to 1972) and within parity groups (nil, 1 or 2, or > 3 term births) and were interviewed in the same way.
Some of the hospitals were added during the course of the study and there were minor differences between the procedures at different periods which were described in our earlier reports. The only important difference was that the upper limit of the age range of the breast cancer patients interviewed was 39y until the end of 1971, and 45y from 1972 to mid-1974. Up to the end of August 1977, the case notes of each patient with cancer treated at any of the London hospitals were reviewed (usually by MV), the treatment was recorded, and clinical information was abstracted to enable the tumour to be staged according to the TNM system (International Union against Cancer, 1968) . So far as possible, this procedure was carried out in the absence of information about the contraceptive practices of the patient concerned. From the beginning of September 1977, the review of the case notes and extraction of clinical information was dropped. All patients with breast cancer treated at the London hospitals have, however, been followed up annually and those dying have been identified.
In the present report the overall results are first presented as simple contingency tables that take no account of the matched design of the study. In subsequent analyses relative risks are estimated, allowance is made for confounding variables, and interactions are sought, using the "adapted" linear logistic procedure described by Breslow et al. (1978) . This method preserves the matching and entails fitting mathematical models for specified sets of variables thought to influence the risk of the disease.
Of 
Results
Use of oral contraceptives As in our earlier analyses, the reference point used to assess the contraceptive histories of the women with breast cancer was taken as the time when the patient first became aware of a lump (or other abnormality) in her breast, with corresponding times for the matched controls. Table I shows the numbers of patients in each group who had been using the pill during the month before the lump was first detected (or during the corresponding month for the controls) together with the numbers who had used oral contraceptives only before that time. Table II shows the interval between the time the pill was first used and the time the lump was detected, and Table III Comparability of the groups The controls were selected for their comparability with the patients with breast cancer with respect to age, parity, marital state and date and hospital of admission. They were also found to be comparable with regard to religion, country of origin, and whether pregnant or in the puerperium. As described in our last full report (Vessey et al., 1979) , the breast cancer patients were of higher social class, had an earlier age at menarche and later age at first term birth, were less often postmenopausal, and more frequently had a history of breast biopsy and a family history of breast cancer than the controls. All these differences are, of course, consistent with the known epidemiology of the disease (Kalache & Vessey, 1982) .
In a previous analysis of 621 pairs of patients (Vessey et al., 1979) we noted that breast cancer patients were less likely to be heavy cigarette This difference was maintained in the later part of the study and was clearly apparent in the complete data (Table V) from which it was estimated that the "relative risk" of breast cancer in heavy smokers in comparison with non-smokers is 0.54:1 (test for trend on data in Table V , P <0.001). We undertook a series of analyses to see if this negative association was merely a reflection of other differences between the women with breast cancer and the controls, especially in terms of social class and age at first term birth. Such adjustment, however, while reducing the smoking association, by no means eliminated it (adjusted relative risk, heavy smokers: non-smokers, 0.67:1, test for trend, P <0.001).
Finally, we examined the use of other reversible methods of contraception by the women in the two groups. Unfortunately, the data available were very rudimentary as we had merely asked each woman if she (or her husband) had at any time used the sheath, the diaphragm, an intrauterine device, withdrawal, the safe period or other birth control methods. The results are shown in Table VI Use of oral contraceptives before the first term birth has been the subject of a separate publication (Vessey et al., 1979) we presented data for users and non-users of oral contraceptives about delay in seeking treatment for breast cancer, about the identity of the individual who first discovered the tumour and about the prevalence of regular breast self examination. We As before, women who had never used oral contraceptives had appreciably more advanced tumours than those who had been using oral contraceptives during the year before detection of the lump ("recent" users), while past users were in an intermediate position.
Mortality ofpatients with breast tumours Of the 572 women with breast cancer included in Table X , 562 were followed until the end of December 1979. There were 182 deaths. All 10 patients who were not followed had emigrated; no attempt was made to trace them after their departure. Table XI gives an analysis of mortality, using the log rank method (Peto et al., 1977) , in relation to oral contraceptive use at the time the tumour was first detected. As in our last analysis, recent users of the pill had a lower mortality than past users, who in turn had a lower mortality than those who had never used the pill. These differences were, however, small and not statistically significant; they almost entirely disappeared after allowance had been made for the effect of clinical stage on survival.
Discussion
Since the appearance of our last detailed report (Vessey et al., 1979) , the results of a considerable number of additional epidemiological studies of the possible association between oral contraceptive use and breast cancer have been published (Paffenbarger et al., 1979; Ravnihar et al., 1979; Jick et al., 1980; Matthews et al., 1981; Pike et al., 1981; Royal College of General Practitioners, 1981; Vessey et al., 1981; Trapido, 1981; Harris et In our last full analysis (Vessey et al., 1979) , we noted that a smaller proportion of women with breast cancer than of matched controls reported never having used any method of birth control at all. The addition of data for a further 555 pairs of patients has left this association unchanged. As a possible explanation, we suggested in 1979 that infertile women, who have less need for contraception, might be less likely to develop breast cancer than fertile women. Our examination of the characteristics of the 120 breast cancer patients and 190 controls who did not admit to the use of birth control, however, makes this explanation unlikelyonly 25% of the former and 19% of the latter had never had any children. We are therefore at something of a loss to explain the difference, although it might, perhaps, mean that women with breast cancer, because of the nature of their illness, are more likely to admit to the use of contraception than controls. Certainly it could be argued that the risks of breast cancer associated with oral contraception should be estimated only from data relating to patients and controls admitting to the use of some birth control method. We have chosen not to adopt this approach in the present paper but it may be noted that, on this basis, the adjusted relative risk of breast cancer among those with any use of oral contraceptives is only 0.80 (as opposed to 0.98 see Table VII ).
The negative association between cigarette smoking and breast cancer was noted in our last full report and has now been consolidated by the collection of additional data. We have been unable to explain the association in terms of any known confounding variable. It is, of course, established that, on average, cigarette smokers have an earlier age of natural menopause than non-smokers (Jick et al., 1977) and, as a consequence, post-menopausal smokers would be expected to be at slightly lower risk of breast cancer than non-smokers. The association that we have observed cannot, however, be explained in terms of this mechanism. It is also possible that smoking might offer some additional protection against breast cancer (MacMahon et al., 1982 ; Baron J., personal communication), but we suspect that the unrepresentative nature of smoking habits amongst our hospital controls-in some of whom cigarette smoking is likely to have contributed to their ill-health-is a likely explanation for our results.
Finally, the small amount of additional information in the present report on clinical stage of breast tumours at diagnosis supports our earlier observation of a negative association between stage and oral contraceptive use. Once again, we found no evidence that this association can be attributed to "surveillance bias" among oral contraceptive users and the possibility of a beneficial effect of contraceptive steroids on tumour growth and spread must be considered.
